CLINICAL_TRIALS
trial_result
· 2012-08-20
Clinical Trial Update: A Study of the Pharmacokinetics of Two Formulations of MK-1006 (MK-1006-010 AM1)(COMPLETED) [Phase 1]
Summary
A Phase 1 pharmacokinetics study comparing two formulations of MK-1006 has completed, with results posted in August 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Type 2 Diabetes | Phase 1 | Status: COMPLETED | Results posted: 2012-08-20